Tech Company Financing Transactions
Lucy Therapeutics Funding Round
On 5/28/2024, Lucy Therapeutics raised $12.5 million in investment from Engine Ventures, Safar & Partners and private investors.
Transaction Overview
Company Name
Announced On
5/28/2024
Transaction Type
Debt
Venture Equity
Venture Equity
Amount
$12,500,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to further its research programs for Alzheimer's and Parkinson's diseases and continue its development of a novel drug target for Rett syndrome.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
21 Hickory Drive 2B
Waltham, MA 02451
USA
Waltham, MA 02451
USA
Phone
Undisclosed
Website
Email Address
Overview
Lucy Therapeutics is a private female-founded biotech company based in Waltham, MA, focused on developing proprietary mitochondrial-based small molecule therapies and diagnostic biomarkers for the treatment of patients with complex diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Amy Ripka
Chief Financial Officer
Bryan Keaney
Chief Scientific Officer
Christopher Winrow
Vice President
Allen Hopper
VP - Operations
Jessica Garrant
Browse more venture capital transactions:
Prev: 5/28/2024: HoneyNaps venture capital transaction
Next: 5/28/2024: Vizcab venture capital transaction
Share this article
About Our Venture Capital Transactions Database
Our team works diligently to document every notable VC transaction. All VC database entries on this site are sourced from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs